Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders.

Tábatha de Oliveira Silva, Guilherme Lunardon, Caroline A Lino, Amanda de Almeida Silva, Shiju Zhang, Maria Cláudia Costa Irigoyen, Yao Wei Lu, John D Mably, Maria Luiza M Barreto-Chaves, Da-Zhi Wang, Gabriela P Diniz

Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil; Center for Regenerative Medicine, USF Health Heart Institute, University of South Florida, Tampa, FL, USA.Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil; Center for Regenerative Medicine, USF Health Heart Institute, University of South Florida, Tampa, FL, USA. · pubmed

Paper

Abstract

Obesity is a major contributor to metabolic and cardiovascular disease. Although senescent cells have been shown to accumulate in adipose tissue, the role of senescence in obesity-induced metabolic disorders and in cardiac dysfunction is not yet clear; therefore, the therapeutic potential of managing senescence in obesity-related metabolic and cardiac disorders remains to be fully defined.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper addresses the role of senescent cells in obesity-related metabolic and cardiac disorders, which is pertinent to understanding the mechanisms of aging and age-related diseases. However, while it presents solid research, it does not offer groundbreaking insights or solutions that significantly advance the field of longevity research. The findings may contribute to the understanding of obesity's impact on aging but do not directly tackle the root causes of aging or lifespan extension.

Author of this paper? Send a correction.